Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CEREVEL THERAPEUTICS HOLDINGS, INC.
01/10CEREVEL THERAPEUTICS TO PRESENT AT 4 : Additional Details of Phase 2 Program for Emraclidi..
AQ
01/05JPMorgan Starts Cerevel Therapeutics Holdings at Overweight With $50 Price Target
MT
01/03Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021Cerevel Agrees Multi-year Collaboration With Herophilus to Research, Develop Therapeuti..
MT
2021HC Wainwright Starts Cerevel Therapeutics Holdings at Buy With $50 Price Target
MT
2021CVL-231 : Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
PU
2021CEREVEL THERAPEUTICS : Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhum..
PU
2021Cerevel Therapeutics Reports Third Quarter 2021 Financial Results and Pipeline Updates ..
PU
2021Cerevel Therapeutics Corporate Presentation
PU
2021Cerevel Therapeutics to Participate at Upcoming Virtual Investor Conferences
AQ
2021CEREVEL THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Wednesday, Novemb..
AQ
2021CEREVEL THERAPEUTICS : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $37 From..
MT
2021CEREVEL THERAPEUTICS : R&D Day Presentation
PU
More most relevant news
All news about CEREVEL THERAPEUTICS HOLDINGS, INC.
01/10CEREVEL THERAPEUTICS TO PRESENT AT 4 : Additional Details of Phase 2 Program for Emraclidi..
AQ
01/05JPMorgan Starts Cerevel Therapeutics Holdings at Overweight With $50 Price Target
MT
01/03Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021Cerevel Agrees Multi-year Collaboration With Herophilus to Research, Develop Therapeuti..
MT
2021HC Wainwright Starts Cerevel Therapeutics Holdings at Buy With $50 Price Target
MT
2021CVL-231 : Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
PU
2021CEREVEL THERAPEUTICS : Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhum..
PU
2021Cerevel Therapeutics Reports Third Quarter 2021 Financial Results and Pipeline Updates ..
PU
More news
News in other languages on CEREVEL THERAPEUTICS HOLDINGS, INC.
2021La directrice financière de Cerevel Therapeutics, Kathy Yi, quitte ses fonctions ; Mark..
2021Cerevel Therapeutics réduit sa perte au deuxième trimestre, mais augmente ses dépenses ..
2021Cerevel Therapeutics propose un placement d'actions ordinaires à 25 dollars par action
2021MISE À JOUR SECTORIELLE : Les actions du secteur de la santé font du surplace près de la c..
2021MISE À JOUR SECTORIELLE : Les actions du secteur de la santé chutent alors que les biotech..
2021Cerevel Therapeutics va vendre 14 millions d'actions dans le cadre d'une offre publique..
2021MISE À JOUR SECTORIELLE : Les actions du secteur de la santé restent sans réaction en fin ..
2021MISE À JOUR SECTORIELLE : Les actions du secteur de la santé affichent de légers gains
2021MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont plates ou en hausse mard..
2021Cerevel Therapeutics déclare que l'essai clinique de phase 1b du candidat médicament co..
More news
Analyst Recommendations on CEREVEL THERAPEUTICS HOLDINGS, INC.
01/05JPMorgan Starts Cerevel Therapeutics Holdings at Overweight With $50 Price Target
MT
2021HC Wainwright Starts Cerevel Therapeutics Holdings at Buy With $50 Price Target
MT
2021CEREVEL THERAPEUTICS : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $37 From..
MT
2021CEREVEL THERAPEUTICS : Morgan Stanley Adjusts Cerevel Therapeutics Holdings PT to $39 From..
MT
2021CEREVEL THERAPEUTICS : Stifel Adjusts Price Target on Cerevel Therapeutics Holdings to $33..
MT
More recommendations
Press releases
01/10CEREVEL THERAPEUTICS TO PRESENT AT 4 : Additional Details of Phase 2 Program for Emraclidi..
AQ
01/03Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021CVL-231 : Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
PU
2021CEREVEL THERAPEUTICS : Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhum..
PU
2021Cerevel Therapeutics Corporate Presentation
PU
More press releases
Upcoming event on CEREVEL THERAPEUTICS HOLDINGS, INC.
03/23/22